![Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure](https://www.jacc.org/cms/asset/d8c3114d-201a-43e8-b42b-ac34be4f2119/fx1.jpg)
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure
![GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253821010656-fx1.jpg)
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect
![Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep29393/MediaObjects/41598_2016_Article_BFsrep29393_Fig1_HTML.jpg)
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports
![Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes](https://www.frontiersin.org/files/Articles/440649/fendo-10-00080-HTML-r1/image_m/fendo-10-00080-g001.jpg)
Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
![IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect](https://www.mdpi.com/ijerph/ijerph-16-02720/article_deploy/html/images/ijerph-16-02720-sch001.png)
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
![Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020 Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020](https://journals.sagepub.com/cms/10.1177/1179551420912972/asset/images/large/10.1177_1179551420912972-fig1.jpeg)
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020
![Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science](https://www.jacc.org/cms/asset/5cf50172-05c6-43c3-9530-3305461a7dca/fx1.jpg)
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science
![Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram](https://www.researchgate.net/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
![Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/86410633-66f9-484f-820c-0f6c5e3ab6b2/gr1.jpg)
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health
![Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-14-00586/article_deploy/html/images/pharmaceuticals-14-00586-g001.png?1624331365)
Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
![DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram](https://www.researchgate.net/publication/343774145/figure/fig2/AS:926657976225795@1597943886841/DPP4-degrade-the-GLP1-and-incretion-which-leads-to-suppression-of-the-insulin.png)
DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram
![Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-33483-y/MediaObjects/41598_2018_33483_Fig1_HTML.png)
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports
![Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2 - ScienceDirect Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0925443914001690-fx1.jpg)